ANASTROZOLE
Generic: ANASTROZOLE
Natco Pharma LimitedManufacturer
ORALRoute
ANASTROZOLEActive Substance
2010-06-28Original Approval
ANASTROZOLE is FDA application ANDA079220, sponsored by NATCO PHARMA LTD. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2019-05-09
Anastrozole Tablets, USP, 1 mg, a) 30-count (NDC 68001-155-04) and 1000-count (NDC 68001-155-08) bottles, Rx Only, ManufGMP Deviations: Potential cross contamination due to cleaning procedure failure.
Class II2019-05-06
Anastrozole Tablets, USP, 1 mg, 1,000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Class II2019-05-09
Anastrozole Tablets, USP, 1mg, 30-count unit dose blisters per carton, Rx Only, Packaged and Distributed by: American HGMP Deviations: Potential cross contamination due to cleaning procedure failure.
Class II2019-05-06
ANASTROZOLE Tablets, 1 mg, Rx Only, 30-count bottle, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India. DistributCGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.
Top Reported Reactions
1
FATIGUE
2,457 reports
2
NAUSEA
1,947 reports
3
DIARRHOEA
1,844 reports
4
ARTHRALGIA
1,621 reports
5
ALOPECIA
1,468 reports
6
HEADACHE
1,212 reports
7
DYSPNOEA
1,116 reports
8
MALIGNANT NEOPLASM PROGRESSION
1,084 reports
9
PAIN
1,071 reports
10
ASTHENIA
1,065 reports